Antithrombotic effect of FK506 vs cyclosporine in cardiac transplant recipients: potential implications in transplant arteriopathy.
暂无分享,去创建一个
[1] P. Meraj,et al. Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[2] H. Valantine,et al. HMG-CoA reductase inhibitors reduce transplant coronary artery disease and mortality: evidence for antigen-independent mechanisms? , 1997, Circulation.
[3] D. Nelson,et al. Hemostasis, fibrinolysis, and natural anticoagulation in transplant vascular sclerosis. , 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[4] Y. Sasaki,et al. Antithrombotic effect of FK506 versus prothrombotic effect of cyclosporine in vivo. , 1995, Transplantation.
[5] P. Libby,et al. Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. , 1991, The American journal of pathology.
[6] V. Fuster,et al. Influence of Arterial Damage and Wall Shear Rate on Platelet Deposition: Ex Vivo Study in a Swine Model , 1986, Arteriosclerosis.
[7] V. Fuster,et al. Spontaneous and Diet‐Induced Coronary Atherosclerosis in Normal Swine and Swine with von Wiiiebrand Disease , 1985, Arteriosclerosis.
[8] V. Fuster,et al. Arteriosclerosis in Normal and von Willebrand Pigs: Long‐Term Prospective Study and Aortic Transplantation Study , 1982, Circulation research.
[9] J. Squifflet,et al. Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine A patients. , 1998, Transplantation proceedings.
[10] U. Naik,et al. Cyclosporine A enhances agonist-induced aggregation of human platelets by stimulating protein phosphorylation. , 1993, Cellular & molecular biology research.